D-1736-2019 Class II Terminated
FDA drug recall D-1736-2019 was initiated by US Pharmaceuticals Inc. on Jul 11, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process. The recall status is terminated (terminated Jun 25, 2020). Affected quantity: 1174 cases.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 21, 2019
- Initiation Date
- Jul 11, 2019
- Termination Date
- Jun 25, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1174 cases
Product description
CVS Health Glycerin Suppositories, 100- count box, Distributed by:Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895. UPC 0 50428 42738 5
Reason for recall
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot #'s 61J17, 62J17, 65J17, 66J17, 67J17, 83J17, 86J17, 87J17 EXP 07/2019; Lot #'s 06P17, 08P17, 09P17, 10P17, 12P17, 13P17, 15P17, 16P17, 17P17, 18P17, 19P17, 21P17, 22P17, 23P17, 24P17 , 26P17 EXP 11/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1736-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026